Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Sep;60(3):397–400. doi: 10.1038/bjc.1989.293

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

P A de Bruin 1, H W Verspaget 1, G Griffioen 1, J H Verheijen 1, G Dooijewaard 1, C B Lamers 1
PMCID: PMC2247195  PMID: 2506920

Abstract

In resection tissue samples of colorectal carcinomas, the concentration of urokinase-type plasminogen activator (u-Pa) was found to be significantly higher than in the normal parent mucosal tissue, while there was less tissue-type plasminogen activator (t-PA). u-PA and t-PA were also determined in endoscopic biopsies of colonic and gastric carcinomas, and the results were compared with those of the ultimate resection samples of the same patients, and with the histological evaluation of adjacent biopsies. The ratio of u-PA/t-PA antigen in the biopsies was found to represent a good discriminator between normal and malignant tissue. Nearly all (90%) tumour biopsies had a higher PA antigen ratio than that of the normal tissue biopsies. This discrimination based upon PA antigen measurements in biopsies was similarly efficient in the subsequent resection samples, and showed a good agreement with the histological evaluation. Thus, PA antigen measurements in endoscopic biopsies can be used to detect gastrointestinal malignancy.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binnema D. J., van Iersel J. J., Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res. 1986 Sep 1;43(5):569–577. doi: 10.1016/0049-3848(86)90077-0. [DOI] [PubMed] [Google Scholar]
  2. Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266. doi: 10.1016/s0065-230x(08)60028-7. [DOI] [PubMed] [Google Scholar]
  3. Dekker W., Tytgat G. N. Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. Gastroenterology. 1977 Oct;73(4 Pt 1):710–714. [PubMed] [Google Scholar]
  4. Duffy M. J., O'Grady P. Plasminogen activator and cancer. Eur J Cancer Clin Oncol. 1984 May;20(5):577–582. doi: 10.1016/0277-5379(84)90001-4. [DOI] [PubMed] [Google Scholar]
  5. Gelister J. S., Mahmoud M., Lewin M. R., Gaffney P. J., Boulos P. B. Plasminogen activators in human colorectal neoplasia. Br Med J (Clin Res Ed) 1986 Sep 20;293(6549):728–731. doi: 10.1136/bmj.293.6549.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kirchheimer J. C., Huber K., Wagner O., Binder B. R. Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas. Br J Haematol. 1987 May;66(1):85–89. doi: 10.1111/j.1365-2141.1987.tb06894.x. [DOI] [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Nishino N., Aoki K., Tokura Y., Sakaguchi S., Takada Y., Takada A. The urokinase type of plasminogen activator in cancer of digestive tracts. Thromb Res. 1988 May 15;50(4):527–535. doi: 10.1016/0049-3848(88)90201-0. [DOI] [PubMed] [Google Scholar]
  9. Rijken D. C., van Hinsbergh V. W., Sens E. H. Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res. 1984 Jan 15;33(2):145–153. doi: 10.1016/0049-3848(84)90175-0. [DOI] [PubMed] [Google Scholar]
  10. Sim P. S., Stephens R. W., Fayle D. R., Doe W. F. Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme. Int J Cancer. 1988 Oct 15;42(4):483–488. doi: 10.1002/ijc.2910420402. [DOI] [PubMed] [Google Scholar]
  11. Suzumiya J., Hasui Y., Kohga S., Sumiyoshi A., Hashida S., Ishikawa E. Comparative study of plasminogen activator antigens in colonic carcinomas and adenomas. Int J Cancer. 1988 Oct 15;42(4):627–632. doi: 10.1002/ijc.2910420426. [DOI] [PubMed] [Google Scholar]
  12. de Bruin P. A., Griffioen G., Verspaget H. W., Verheijen J. H., Dooijewaard G., van den Ingh H. F., Lamers C. B. Plasminogen activator profiles in neoplastic tissues of the human colon. Cancer Res. 1988 Aug 15;48(16):4520–4524. [PubMed] [Google Scholar]
  13. de Bruin P. A., Griffioen G., Verspaget H. W., Verheijen J. H., Lamers C. B. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas. Cancer Res. 1987 Sep 1;47(17):4654–4657. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES